Carlyle Group Inc.Carlyle Group Inc.

Institutional investor · Portfolio as of Q2 2019

SEC EDGAR SourceSEC Filings

Top Holdings11 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

LIBERTY ENERGY INC

47.8M$773.5M38.4%$11.90+26.30%
3 qtrssince 2018-Q4
Unchanged
0
EVAEVA
Unit

ENVIVA PARTNERS LP

11.2M$350.5M17.4%
3 qtrssince 2018-Q4
Unchanged
0
172.9M$337.2M16.8%
2 qtrssince 2019-Q1
Unchanged
0

WESCO AIRCRAFT HOLDINGS INC

23.1M$256.4M12.7%
3 qtrssince 2018-Q4
Unchanged
0
31M$246.9M12.3%
3 qtrssince 2018-Q4
Increased
80

SEACOR MARINE HLDGS INC

1.1M$15.9M0.8%$12.00+24.66%
3 qtrssince 2018-Q4
Increased
45
1.3M$9.9M0.5%
3 qtrssince 2018-Q4
Unchanged
0
CIHCIHDelisted
ADR

CHINA INDEX HLDGS LTD

2.5M$8.7M0.4%
1 qtr
New
49
12.3M$7.6M0.4%
3 qtrssince 2018-Q4
Unchanged
0
6.4M$3.5M0.2%
3 qtrssince 2018-Q4
Unchanged
0

Sweetgreen, Inc.

174,170$2M0.1%
3 qtrssince 2018-Q4
Unchanged
0
$2B
AUM
11
Positions
Q2 2019
Filing
Rating · 1.5
Quarterly Portfolio Change
Not enough history yet
Activity profile
$ moved · Q2'19
New10%Increased79%Decreased0%Exited11%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.7 quarters
<1Q9%1-4Q91%1-2Y0%2Y+0%

Carlyle Group Inc. manages $2B across 11 positions as of Q2 2019. Top holdings: LBRT (38.4%), EVA (17.4%), CS1 (16.8%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 1.5/5.0.

Q2 2019 Summary

Added 1 new position, exited 1, increased 2. Top move: CIH (NEW, conviction 49). Portfolio: $2.0B across 11 positions.

Top holdings by portfolio weight

Total AUM$2B
LBRT38.44%
EVA17.42%
CS116.76%
WAIR12.74%
ONESMART INT12.27%
SMHI0.79%
CDEV0.49%
CIH0.43%
SFUN0.38%
SEQUENTIAL B0.17%
Other0.10%

Portfolio allocation by GICS sector

Sectors4
Unknown55.08%
Energy43.90%
Industrials0.90%
Consumer Cyclical0.11%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Unknown, Energy
Compare DNA across all funds
7-dimension quality assessment
Below Average(1.5 / 5.0)
Track RecordNo data
Conviction38
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used